MedTrace Logo

First-in-man Sirolimus-eluting Prolim® Stent Registry

NCT02545985 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2015-09-15

No results posted yet for this study

Summary

The aim of this study was to assess the safety and the efficacy of the novel sirolimus-eluting Prolim® stent with a biodegradable polymer in the all-comers population.

Conditions

  • Sirolimus-eluting Stainless Steel Coronary Stent Prolim®

Interventions

DEVICE

Prolim stent deployment

Prolim stent was implanted in patients who signed the informed consent and met the exclusion and inclusion criteria.

Sponsors & Collaborators

  • Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Jacek Bil, MD, PhD · Central Clinical Hospital of the Ministry of Internal Affairs

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-03-31
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545985 on ClinicalTrials.gov